Title:
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/001237
Kind Code:
A1
Abstract:
Disclosed are compounds of formula I or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods related to agonists of glucagon-like peptide-1 receptor (GLP-1R). In particular, the compounds and compositions may be used to treat GLP-1R-related disorders and conditions, including, e.g., obesity, T2DM, NAFLD, NASH as disclosed herein.
Inventors:
XU XIAODONG (CN)
MO CHENG (CN)
CHEN SHIJIA (CN)
MO CHENG (CN)
CHEN SHIJIA (CN)
Application Number:
PCT/CN2022/107047
Publication Date:
January 26, 2023
Filing Date:
July 21, 2022
Export Citation:
Assignee:
HEPAGENE THERAPEUTICS HK LTD (CN)
International Classes:
C07D413/14; A61K31/4427; A61K31/497; A61P3/10; C07D401/14; C07D405/14; C07D487/04
Domestic Patent References:
| WO2019239319A1 | 2019-12-19 | |||
| WO2018109607A1 | 2018-06-21 | |||
| WO2020207474A1 | 2020-10-15 | |||
| WO2019239371A1 | 2019-12-19 | |||
| WO2020103815A1 | 2020-05-28 | |||
| WO2021018023A1 | 2021-02-04 |
Attorney, Agent or Firm:
CHENG & PENG INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: TOUCH DETECTION AND FEEDBACK SYSTEM AND METHOD
Next Patent: PERSONAL MOBILITY VEHICLE
Next Patent: PERSONAL MOBILITY VEHICLE